Published in Psychopharmacology (Berl) on December 27, 2016
Moderators of smoking cessation outcomes in a randomized-controlled trial of varenicline versus placebo. Psychopharmacology (Berl) (2017) 0.77
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict (1991) 63.91
The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev (1993) 19.60
Ecological momentary assessment. Annu Rev Clin Psychol (2008) 13.68
Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry (1986) 10.11
Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev (2004) 9.30
Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol (2006) 8.02
Development and validation of the Wisconsin Smoking Withdrawal Scale. Exp Clin Psychopharmacol (1999) 3.21
Relapse to smoking. Clin Psychol Rev (2005) 2.73
Life before and after quitting smoking: an electronic diary study. J Abnorm Psychol (2006) 2.30
How much unsuccessful quitting activity is going on among adult smokers? Data from the International Tobacco Control Four Country cohort survey. Addiction (2012) 2.13
Smoking withdrawal dynamics in unaided quitters. J Abnorm Psychol (2000) 2.11
Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal. JAMA Psychiatry (2013) 2.11
Dimensions of depressive symptoms and smoking cessation. Nicotine Tob Res (2008) 2.06
Relapse prevention: introduction and overview of the model. Br J Addict (1984) 2.05
Imaginary relish and exquisite torture: the elaborated intrusion theory of desire. Psychol Rev (2005) 2.05
Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention. J Consult Clin Psychol (2010) 1.99
Tobacco withdrawal in self-quitters. J Consult Clin Psychol (1992) 1.94
DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM-5. Addiction (2012) 1.81
Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. J Abnorm Psychol (2003) 1.79
Addiction as a stress surfeit disorder. Neuropharmacology (2013) 1.68
Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations. J Abnorm Psychol (2003) 1.64
Tobacco withdrawal components and their relations with cessation success. Psychopharmacology (Berl) (2011) 1.60
beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking. Arch Gen Psychiatry (2009) 1.53
Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review. Nicotine Tob Res (2007) 1.43
A comparison of the psychometric properties of three cigarette withdrawal scales. Addiction (2006) 1.33
Do point prevalence and prolonged abstinence measures produce similar results in smoking cessation studies? A systematic review. Nicotine Tob Res (2010) 1.32
Effects of anhedonia on days to relapse among smokers with a history of depression: a brief report. Nicotine Tob Res (2010) 1.22
A systematic review of the relationships between craving and smoking cessation. Nicotine Tob Res (2013) 1.21
Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence. Drug Alcohol Depend (2010) 1.15
Early cessation success or failure among women attempting to quit smoking: trajectories and volatility of urge and negative mood during the first postcessation week. J Abnorm Psychol (2011) 1.11
EEG, physiology, and task-related mood fail to resolve across 31 days of smoking abstinence: relations to depressive traits, nicotine exposure, and dependence. Exp Clin Psychopharmacol (1999) 1.10
Neurotransmission-related genetic polymorphisms, negative affectivity traits, and gender predict tobacco abstinence symptoms across 44 days with and without nicotine patch. J Abnorm Psychol (2009) 0.94
Does nicotine withdrawal affect smoking cessation? Clinical and theoretical issues. Ann Behav Med (1996) 0.92
Increase in anger symptoms after smoking cessation predicts relapse. Drug Alcohol Depend (2008) 0.91
Comparative dynamics of four smoking withdrawal symptom scales. Addiction (2012) 0.88
Platelet monoamine oxidase B activity changes across 31 days of smoking abstinence. Nicotine Tob Res (2003) 0.85
DRD2-related TaqIA polymorphism modulates motivation to smoke. Nicotine Tob Res (2009) 0.84
Smoking cessation in the workplace: evaluation of relapse factors. Prev Med (1990) 0.83
Structural and predictive equivalency of the Wisconsin Smoking Withdrawal Scale across three racial/ethnic groups. Nicotine Tob Res (2011) 0.80
Trajectories in cigarette dependence as a function of anxiety: a multilevel analysis. Drug Alcohol Depend (2014) 0.79
Tobacco withdrawal symptoms mediate motivation to reinstate smoking during abstinence. J Abnorm Psychol (2015) 0.79
Modeling intensive longitudinal data with mixtures of nonparametric trajectories and time-varying effects. Psychol Methods (2015) 0.78